相关实验视频
Updated: May 26, 2025
08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.1K
循环RNA在抗癌治疗中的作用
Wenjuan Liu1, Jiling Niu2, Yanfei Huo1
1Shandong Provincial Key Laboratory of Precision Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China.
Molecular cancer
|February 25, 2025
概括
循环RNAs (circRNAs) 是癌症中的关键遗传分子,影响药物耐药性和免疫逃脱. 本综述探讨了它们在各种癌症中的作用和抵抗机制,强调了它们作为生物标志物和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 循环RNAs (circRNAs) 被认为是一种新型的遗传分子类.
- 许多circRNAs涉及癌症的发病,影响耐药性,免疫逃脱和放射性耐药性.
- 外体circRNAs介导瘤细胞和微环境细胞之间的通信,影响瘤的进展和治疗耐药性.
研究的目的:
- 审查关于关键circRNAs在癌症治疗中的作用和抵抗机制的最新发现.
- 讨论circRNAs作为生物标志物和治疗点的临床相关性和实用性.
- 涵盖各种恶性瘤,包括肺癌,乳腺癌,肝癌,结肠直肠癌,胃癌,血液瘤和神经母细胞瘤.
主要方法:
- 关于癌症中circRNAs的最近研究的文献综述.
- 分析circRNA表达模式及其与癌症特异性的关联.
- 关于circRNA介导的抗性机制的信息综合.
主要成果:
- 循环RNAs在癌症的发展和治疗耐药性方面发挥着重要作用.
- 外体circRNAs在瘤微环境中的细胞间通信中至关重要.
- 观察到环RNAs的组织和癌症特异性表达模式.
- 循环RNA显示出作为癌症早期诊断的生物标志物和治疗点的潜力.
结论:
- 循环RNA是新型癌症生物标志物和治疗策略的有希望的候选者.
- 了解circRNA功能可以改善恶性瘤的早期诊断和治疗.
- 对circRNAs的进一步研究将有助于开发向癌症疗法.
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K